Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up
Titel:
Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up
Auteur:
Fradet, Y. Bellmunt, J. Vaughn, D.J. Lee, J.L. Fong, L. Vogelzang, N.J. Climent, M.A. Petrylak, D.P. Choueiri, T.K. Necchi, A. Gerritsen, W. Gurney, H. Quinn, D.I. Culine, S. Sternberg, C.N. Nam, K. Frenkl, T.L. Perini, R.F. de Wit, R. Bajorin, D.F.